Varian Announces Global Clinical Consortium to Develop Evidence-based Protocols for Adaptive Radiotherapy

PALO ALTO, Calif., April 26, 2019 /PRNewswire/ -- Bringing together a global community of clinicians and scientists from leading cancer clinics to develop best practices for adaptive radiotherapy based on clinical evidence, Varian (NYSE: VAR) today announced it is forming the Adaptive...

from PR Newswire: https://prn.to/2L2bNyA